Roche gets USFDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis Ruchika Sharma11 April 2024 12:17 PMBasel: Roche has announced that its Elecsys pTau217 assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration...
USFDA delays decision on Eli Lilly Alzheimer's drug Donanemab Ruchika Sharma10 March 2024 11:00 AMWhite said the FDA wants the expert panel to discuss some of the unique aspects of the clinical trial used in its request for a traditional FDA...
Study says erectile dysfunction drugs show potential in Alzheimer's prevention Roshni Dhar9 Feb 2024 1:00 PMErectile dysfunction drugs, which work by dilating blood vessels to allow more blood to flow through, were first developed to treat high blood...
Bizarre visual symptoms an early warning for Alzheimer's Disease finds study Niveditha Subramani23 Jan 2024 2:43 PMAlzheimer's characterized by symptoms of dementia still has no cure and several studies are evaluating different factors for its early indication for...
Biogen, Eisai get Japanese nod for Leqembi Intravenous Infusion for Alzheimer's Disease Ruchika Sharma25 Sept 2023 7:00 AMTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody LEQEMBI...
Health Bulletin 02/August/2023 Roshni Dhar2 Aug 2023 11:35 AMHere are the top health stories for the day:Comparing Timeliness and Reliability of Medical Information: Google vs. ChatGPTAn interdisciplinary study...
Medical Bulletin 1/August/2023 Roshni Dhar1 Aug 2023 10:00 AMHere are the top medical news of the day:Novel vaccine may hold key to prevent or reduce the impact of Alzheimer’s diseaseAlzheimer’s disease now...
Eli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference Ruchika Sharma19 July 2023 7:09 AMIndianapolis: Eli Lilly and Company has presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly...
Medical Bulletin 18/July/2023 Isra Zaman18 July 2023 9:45 AMHere are the top medical news for the day: Alzheimer's diagnosis new GuidelinesRecently, at the International Alzheimer's Congress (AAIC) in...
USFDA grants traditional approval for Eisai Leqembi for Alzheimer's disease treatment Ruchika Sharma7 July 2023 8:00 AMStockholm:BioArctic AB's (publ)partner Eisai has announced that the U.S. Food and Drug Administration, FDA, has approved the supplemental Biologics...
Eisai seeks marketing nod for Lecanemab for early Alzheimer's disease treatment in South Korea Ruchika Sharma11 Jun 2023 7:15 AMLecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of...
USFDA advisory committee votes unanimously to confirm clinical benefit of Leqembi for Alzheimer's Disease Ruchika Sharma10 Jun 2023 8:00 AMTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System...
